UniCredit buys further 11.5% of Commerzbank in derivatives as it applies to get to 29.9%-March 2024-www.financetom.com

UniCredit buys further 11.5% of Commerzbank in derivatives as it applies to get to 29.9%

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

UniCredit buys further 11.5% of Commerzbank in derivatives as it applies to get to 29.9%

Oct 3, 2024 12:31 AM

MILAN (Reuters) - UniCredit said it had acquired on Monday, through financial instruments, a further 11.5% of Commerzbank after applying to supervisors to reach a holding of up to 29.9% in the German rival.

"The physical settlement under the new financial instruments may only occur after the required approvals have been obtained," UniCredit said in a note.

When taking into account the initial 9%, UniCredit's overall position now totals around 21%, it said.

Previous page： Billionaire Investor Carl Icahn, Southwest Gas Amend Cooperation Agreement Next page： Marinus Pharmaceuticals Gets New US Patent for Ztalmy Titration Regimens; Shares Rise After Hours

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Billionaire Investor Carl Icahn, Southwest Gas Amend Cooperation Agreement

Oct 15, 2024

According to SEC filings, Southwest Gas Holdings, Inc. ( SWX ) and activist investor Carl Icahn have entered into an amended and restated cooperation agreement. The Details: The updated cooperation agreement provides for participation by the Icahn designees, Andrew W. Evans, Henry P. Linginfelter, Ruby Sharma and Andrew J. Teno, in the Strategic Transactions Committee and the other committees of...

Marinus Pharmaceuticals Gets New US Patent for Ztalmy Titration Regimens; Shares Rise After Hours

Oct 15, 2024

05:47 PM EDT, 10/15/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) said late Tuesday it secured a new patent from the US Patent and Trademark Office for Ztalmy, or ganaxolone, oral titration regimens covering the treatment of various epilepsy disorders. The patent is scheduled to expire in September 2042, the company said. Marinus shares were up 5.2% in after-hours...

Debt boom hits pause Down Under as US election looms

Oct 15, 2024

SYDNEY (Reuters) - Australian dollar debt sales, running at the fastest clip on record, are starting to hit the brakes as capital markets hunker down for the U.S. election, according to bankers in Sydney. Some A$267.6 billion ($180.4 billion) has been raised in the debt market over the year to Oct. 8, the largest figure on Dealogic records stretching back...

Jfrog Insider Sold Shares Worth $462,757, According to a Recent SEC Filing

Oct 15, 2024

05:37 PM EDT, 10/15/2024 (MT Newswires) -- Yoav Landman, Director, CTO, on October 11, 2024, sold 15,000 shares in Jfrog ( FROG ) for $462,757. Following the Form 4 filing with the SEC, Landman has control over a total of 6,612,242 shares of the company, with 6,612,242 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1800667/000141588924025136/xslF345X05/form4-10152024_091005.xml ...